Pacira BioSciences, Inc. — Director's Dealing 2019

Nov 12, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pacira BioSciences, Inc. (PCRX)
CIK: 0001396814
Period of Report: 2019-11-11

Reporting Person: Riker Lauren Bullaro (Vice President, Finance)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-11-11	Common Stock	M	4820	$10.34	Acquired	15460	Direct
2019-11-11	Common Stock	M	180	$10.81	Acquired	15640	Direct
2019-11-11	Common Stock	S	5000	$43.59	Disposed	10640	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-11-11	Stock Option (Right to Buy)	$10.34	M	4820	Disposed	2021-05-10	Common Stock (4820)	Direct
2019-11-11	Stock Option (Right to Buy)	$10.81	M	180	Disposed	2022-06-05	Common Stock (180)	Direct

Footnotes

F1: Includes 598 shares of common stock acquired under the issuer's employee stock purchase plan in June 2019.

F2: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.50 to $43.96, inclusive. The reporting person undertakes to provide to the issuer, any shareholder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3: The option vested and became exercisable as to 25% of the option shares on May 2, 2012 and vested as to the remaining shares in successive equal monthly installments over the subsequent 36 months.

F4: The option vested and became exercisable as to 25% of the option shares on June 5, 2013 and vested as to the remaining shares in successive equal monthly installments for the subsequent 36 months.